133 related articles for article (PubMed ID: 36767582)
1. The Awareness and Adherence of the Valproate Pregnancy Prevention Program: A Questionnaire Survey among Healthcare Professionals, Pharmacists, and Patients in Denmark.
Oliveri NMB; Hansen JM; Almarsdóttir AB; Jacobsen R
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767582
[TBL] [Abstract][Full Text] [Related]
2. Awareness, knowledge and practice of healthcare professionals following implementation of a Pregnancy Prevention Program for sodium valproate in Ireland: a multi-stakeholder cross-sectional study.
Hughes JE; Buckley N; Looney Y; Kirwan G; Curran S; Doherty CP; Mullooly M; Bennett KE
Expert Opin Drug Saf; 2021 Aug; 20(8):965-977. PubMed ID: 34080507
[TBL] [Abstract][Full Text] [Related]
3. Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.
de Vries ST; van der Sar MJM; Coleman AM; Escudero Y; Rodríguez Pascual A; Maciá Martínez MÁ; Cupelli A; Baldelli I; Šipić I; Andrić A; Michan L; Denig P; Mol PGM;
Drug Saf; 2018 Jul; 41(7):713-724. PubMed ID: 29500798
[TBL] [Abstract][Full Text] [Related]
4. Evaluating awareness, knowledge and practice of healthcare professionals following implementation of a revised pregnancy prevention programme for isotretinoin in Ireland: A multi-stakeholder cross-sectional study.
Hughes JE; Buckley N; Looney Y; Kirwan G; Mullooly M; Bennett KE
Pharmacoepidemiol Drug Saf; 2023 Feb; 32(2):137-147. PubMed ID: 36073295
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Risk Minimization Measures to Prevent Pregnancy Exposure to Mycophenolate-Containing Medicines in Europe.
Madison T; Donner B; Mutter R; Mingrino R; Alvaro G
Pharmaceut Med; 2019 Oct; 33(5):395-406. PubMed ID: 31933233
[TBL] [Abstract][Full Text] [Related]
6. Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.
Gils C; Pottegård A; Ennis ZN; Damkier P
BMC Pregnancy Childbirth; 2016 Aug; 16():226. PubMed ID: 27531162
[TBL] [Abstract][Full Text] [Related]
7. The implementation of risk minimization measures to prevent teratogenic pregnancy outcomes related to oral retinoid and valproate use in Belgium.
Bertels X; Mehuys E; Boussery K; Lahousse L
Acta Clin Belg; 2022 Oct; 77(5):815-822. PubMed ID: 34569444
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
[TBL] [Abstract][Full Text] [Related]
9. Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.
Abtahi S; Pajouheshnia R; Durán CE; Riera-Arnau J; Gamba M; Alsina E; Hoxhaj V; Andersen M; Bartolini C; Kristiansen SB; Brown J; Hallgreen CE; Garcia-Poza P; Gardarsdottir H; Gini R; Girardi A; Holthuis E; Huerta C; Ibánez L; Limoncella G; Martín-Pérez M; Paoletti O; Roberto G; Souverein P; Swart KMA; Wing K; Sturkenboom M; Klungel O
Drug Saf; 2023 Jul; 46(7):689-702. PubMed ID: 37294532
[TBL] [Abstract][Full Text] [Related]
10. Compliance with Prescribing and Dispensing Conditions for Valproate and Related Substances in Girls and Women of Childbearing Potential: A Survey of Community Pharmacists in France.
Fauvelle K; Bigna JJ
Drug Saf; 2023 Feb; 46(2):121-128. PubMed ID: 36287388
[TBL] [Abstract][Full Text] [Related]
11. Communication on Safety of Medicines in Europe: Current Practices and General Practitioners' Awareness and Preferences.
de Vries ST; van der Sar MJM; Cupelli A; Baldelli I; Coleman AM; Montero D; Šipić I; Andrić A; Wennberg A; Ahlqvist-Rastad J; Denig P; Mol PGM;
Drug Saf; 2017 Aug; 40(8):729-742. PubMed ID: 28540672
[TBL] [Abstract][Full Text] [Related]
12. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.
Crijns I; Mantel-Teeuwisse A; Bloemberg R; Pinas E; Straus S; de Jong-van den Berg L
Expert Opin Drug Saf; 2013 Jan; 12(1):29-38. PubMed ID: 23163396
[TBL] [Abstract][Full Text] [Related]
13. Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland.
O'Callaghan J; Bermingham M; Leonard M; Hallinan F; Morris JM; Moore U; Griffin BT
Regul Toxicol Pharmacol; 2017 Aug; 88():252-261. PubMed ID: 28666961
[TBL] [Abstract][Full Text] [Related]
14. Enhancing provision of written medicine information in Australia: pharmacist, general practitioner and consumer perceptions of the barriers and facilitators.
Hamrosi KK; Raynor DK; Aslani P
BMC Health Serv Res; 2014 Apr; 14():183. PubMed ID: 24754890
[TBL] [Abstract][Full Text] [Related]
15. A Qualitative Study of Prescription Contraception Use: The Perspectives of Users, General Practitioners and Pharmacists.
Sweeney LA; Molloy GJ; Byrne M; Murphy AW; Morgan K; Hughes CM; Ingham R
PLoS One; 2015; 10(12):e0144074. PubMed ID: 26633191
[TBL] [Abstract][Full Text] [Related]
16. National compliance with UK wide guidelines for usage of valproate in women of childbearing potential.
Eriksson SH; Tittensor P; Sisodiya SM
Seizure; 2022 May; 98():8-12. PubMed ID: 35395505
[TBL] [Abstract][Full Text] [Related]
17. Is the Medicines and Healthcare products Regulator Agency (MHRA) guidance on sodium valproate acceptable to women of childbearing age?
Morrison I; Cork H; Smith P; Campbell C; Megan McTiernan M; White K
J R Coll Physicians Edinb; 2020 Jun; 50(2):114-117. PubMed ID: 32568279
[TBL] [Abstract][Full Text] [Related]
18. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
[TBL] [Abstract][Full Text] [Related]
19. Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists.
Timmers L; Boons CC; Verbrugghe M; van den Bemt BJ; Van Hecke A; Hugtenburg JG
BMC Cancer; 2017 Feb; 17(1):122. PubMed ID: 28187759
[TBL] [Abstract][Full Text] [Related]
20. Prenatal exposure to valproate and risk of congenital malformations-Could we have known earlier?-A population-based cohort study.
Christensen J; Trabjerg BB; Sun Y; Gilhus NE; Bjørk MH; Tomson T; Dreier JW
Epilepsia; 2021 Dec; 62(12):2981-2993. PubMed ID: 34585373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
